The insulinotropic activity of these Ficus deltoidea varieties suggests that they can potentially be developed as a new phytopharmaceutical agent for the management of diabetes mellitus potentially for escalation of insulin secretion from insulin producing cells. The gene discussed is INS; the disease is diabetes mellitus.